Extending the period of treatment with antiviral drugs after a kidney or pancreas transplant is a cost-effective way to prevent cytomegalovirus infections that often lead to devastating consequences.
Transplant Patients Benefit from Longer Antiviral Course (CME/CE...Courtesy MedPage Today Infectious Disease Thu, 09/17/2009 - 15:00
Extending the period of treatment with antiviral drugs after a kidney or pancreas transplant is a cost-effective way to prevent cytomegalovirus infections that often lead to devastating consequences. More related itemsStatins may reduce mortality in patients hospitalized...
Pinkeye Treatment May Be on the Horizon
‘Artificial Pancreas’ May Treat Type 1 Diabetes
|
Popular by tags WeekMonth |
Post new comment